Exagen Inc (NASDAQ:XGN) currently has a daily average trading volume of 221.94K but it saw 285134 shares traded in last market. With a market cap of 160.85M USD, the company’s current market price of $7.36 came falling about -4.79 while comparing to the previous closing price of $7.73. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.82 and as low as $1.71. In the recent trading on the day, stock has struck highest price mark of $7.3 while lowest mark touched by it was $7.95.
Canaccord Genuity issued its recommendations for the stock as it initiated the price target for the stock is $25.
Over the week, XGN’s stock price is moving 1.38% up while it is 16.27% when we observe its performance for the past one month. Year-to-date it is 79.51% up and over the past year, the stock is showing an upside performance of 275.51%.
The company is expected to be releasing its next quarterly report on 2025-May-05, for which analysts forecasted an EPS of -0.15 while estimate for next year EPS is -0.57. In next quarter, company is expected to be making quarterly sales of $16.5M as analysts are expecting the sales for current fiscal year at $65.82M and seeing the company making $74.72M in sales next year. Moreover, analysts are in estimates of $16.25M for current-quarter revenue.
Currently, Exagen Inc’s total number of outstanding shares is 17.95M. Company’s return on investment (ROI) stands at -59.24% and return on equity (ROE) at -117.50%. Stock’s beta reads 1.60. Stock has a price to book (P/B) ratio of 20.63 while price to sale or P/S ratio amounts to 2.84. Its return on asset (ROA) is -34.04% on average.
